Pharmaceutical Executive-03-01-2015

Pharmaceutical Executive

Will FDA Fixes Spur Innovation?

March 16, 2015

Columns

35

3

Congress, Obama offer strategies to reduce regulatory roadblocks to new breakthroughs.

23andMe’s Double Play: Making Science & Patients Partners

March 11, 2015

Features

35

3

Pharm Exec profiles patient DNA partnering advocate 23andMe, which recently struck data deals with a pair of big Pharmas, thrusting the debate over personal genomics and patient treatment back into high gear.

Tomorrow’s Selling Strategies: Invest & Test

March 08, 2015

Features

35

3

A new PwC survey reveals a strong need to fully embrace alternative commercial methods-not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.